American Well Corp
American Well Corp, which operates as Amwell, builds digital care software and services for healthcare organizations. Its core offering is the Amwell Platform, an enterprise telehealth and hybrid-care platform sold mainly through recurring subscriptions, with add-on professional services, Carepoint devices, and clinical services delivered through its affiliated provider network. The company serves health plans, health systems, and other healthcare organizations that want to extend care delivery beyond the traditional clinic setting. Amwell also sells virtual clinical services and digital mental health capabilities, including SilverCloud by Amwell, to support behavioral health and broader care access. The business is positioned around enabling synchronous, asynchronous, and automated care workflows across the healthcare continuum.
Fiscal year 2025 · change from previous year
Development 2020–2025
Business
Share of revenueRecurring access to the Amwell Platform and SaaS modules used to run virtual and hybrid care workflows.
Fee-for-service provider visits and affiliated medical staffing delivered through AMG.
Implementation, workflow design, systems integration, and adoption support for customers.
Carepoint devices, cart fleet management, and related operational support for care delivery.
SilverCloud and patient/provider engagement tools that expand use cases and utilization.
Products
Reported · share of revenue- Platform Subscription53.1 %
- Visits37.8 %
- Others9.1 %
Source: 10-K FY2025, revenue the company reports per product line (SEC XBRL). Shares are of the lines shown and add up to 100 %.
Customers
Amwell primarily sells to healthcare organizations rather than individual consumers, with health plans and health systems forming the core customer base. Health plans use the platform to improve access, member engagement, and cost management, while health systems use it to extend provider capacity, support virtual visits, and integrate digital care into existing workflows. The company also serves provider networks and other healthcare organizations that need supplemental clinical supply, specialty coverage, or patient engagement tools. Customer adoption depends on utilization: the more visits and workflows clients run through the platform, the more likely they are to renew, expand, and generate clinical-fee revenue. The company’s largest client concentration is material, with Elevance Health representing a significant share of revenue.
Buy subscription access and clinical services to manage member access, engagement, and care costs through virtual and hybrid care.
Buy enterprise platform access, integration services, and provider capacity tools to support virtual care and specialty workflows.
Use fee-for-service clinical staffing and visit capacity when customers need supplemental clinicians or expanded coverage.
Buy SilverCloud and related digital behavioral health tools to extend access and support patient engagement.
Use consumer-facing virtual care services for on-demand access, though this is not the main revenue engine.
Strategy
Amwell’s strategy is to expand utilization of the Amwell Platform so that existing customers renew, broaden use cases, and generate more subscription and clinical-service revenue. Management is focused on growing within health plans and health systems while opening the platform to third-party innovators and EHR integrations, which should make the platform more embedded in customer workflows. The company is also reducing its cost structure through strategic transformation actions, including headcount reductions and consulting, to align expenses with its current revenue base. International expansion, especially in behavioral health through SilverCloud, is another priority because it enlarges the addressable market beyond the U.S. core. The business model depends on converting platform adoption into recurring usage, so utilization growth is central to both competitive positioning and operating leverage.
Higher visit volumes and workflow adoption increase subscription value and clinical-fee revenue.
Deeper interoperability makes the platform stickier and more relevant inside customer care workflows.
International digital mental health broadens the addressable market beyond the U.S. core.
Expense discipline is needed because the company continues to operate at a loss.
Geography
Amwell is headquartered in the United States and the U.S. remains the core market for its platform, clinical services, and customer base. The company estimates a large domestic addressable market and identifies significant U.S. demand across health plans, health systems, and software-enabled virtual care use cases. It also has international exposure through SilverCloud and other global expansion efforts, with clients in Israel, Europe, and Australia. The company maintains offices in the United States, Ireland, Colombia, and Israel, which supports product development, operations, and international delivery. Geography matters because healthcare licensing, privacy, data storage, and regulatory requirements differ by country and can affect product design and service delivery.
Risks
Amwell remains exposed to persistent operating losses, and management states it expects losses to continue, which makes execution on growth and cost control critical. Revenue concentration is a major company-specific risk because Elevance Health accounts for a large share of revenue, so contract loss or repricing would materially affect results. The digital care market is still evolving, and slower-than-expected adoption by patients, providers, or health plans could limit utilization and renewal rates. The company also faces intense competition from telehealth specialists, EHR vendors, and large technology platforms, which can pressure pricing and customer retention. In addition, healthcare regulation, privacy and cybersecurity obligations, and international geopolitical exposure create operational and compliance risk across the business.
- Customer concentrationImpact: HighLikelihood: High
A small number of large clients drive a disproportionate share of revenue, so churn or pricing pressure can materially reduce sales.
Exposure: Elevance Health represented 31% of revenue in 2025.
- Ongoing operating lossesImpact: HighLikelihood: High
The company continues to burn cash and may need to keep funding growth and restructuring before reaching profitability.
- Digital care adoption riskImpact: HighLikelihood: High
The business depends on patients and providers using the platform frequently enough to justify renewals and expansion.
- Privacy and cybersecurity complianceImpact: HighLikelihood: Medium
The company handles sensitive health data and operates in a heavily regulated environment, so breaches or compliance failures could create liability.
- Competition from telehealth and platform vendorsImpact: MediumLikelihood: High
Competitors include specialized telehealth firms, EHR vendors, and horizontal tech platforms that can compete on functionality and distribution.
- International regulatory and geopolitical exposureImpact: MediumLikelihood: Medium
Operations and clients outside the U.S. face country-specific licensing, data, and political risks.
Exposure
Accounting
Judgemental itemsThe company sells subscriptions, fee-for-service visits, professional services, and devices, each of which can be recognized differently.
Impact: Affects revenue timing, quarterly comparability, and deferred revenue balances
Subscription billing and service prepayments create deferred revenue that later converts into reported revenue.
Impact: Important for cash flow analysis and renewal visibility
Management must test acquired assets for impairment, and prior write-downs show sensitivity to valuation assumptions.
Impact: Can create large non-cash charges and reduce reported equity
Headcount reductions and consulting costs are part of restructuring the cost base.
Impact: Can cause non-recurring expense spikes and affect operating margin
A meaningful non-cash expense in a company that continues to invest heavily in talent.
Impact: Raises reported operating costs and affects earnings quality
Similar listed companies
Publicly listed companies with a comparable business focus.
Elevance Health, Inc.
ELV · Hospital & Medical Service Plans
Elevance Health is a U.S.
MedWellAI, Inc.
MWAI · Finance Services
CorVel Corp
CRVL · Insurance Agents, Brokers & Service
CorVel Corp provides managed care services that help employers, insurers, TPAs, and government-related buyers control medical costs and manage claims,…
Evolent Health, Inc.
EVH · Services-Management Services
Amneal Pharmaceuticals, Inc.
AMRX · Pharmaceutical Preparations
Amneal Pharmaceuticals is a U.S.-based diversified biopharmaceutical company that develops, manufactures, markets, and distributes essential medicines across…
Amentum Holdings, Inc.
AMTM · Services-Business Services, NEC
Last updated: 24/09/2026